# MEDICATION FIELD-BOUNDARY EXTRACTION IMPLEMENTATION REPORT

**Implementation Status:** COMPLETE  
**Date:** October 7, 2026  
**Authority:** Forensically validated findings from [`reports/MEDICATION_BOUNDARY_FORENSIC_AUDIT.md`](file:///d:/daa/reports/MEDICATION_BOUNDARY_FORENSIC_AUDIT.md)  
**Production Target:** [`src/clindoc/extract/llm_extractor.py`](file:///d:/daa/src/clindoc/extract/llm_extractor.py)  
**Test Suite Target:** [`tests/test_medication_boundaries.py`](file:///d:/daa/tests/test_medication_boundaries.py)  
**Git Status:** Completely unstaged and uncommitted (strictly adheres to evaluation guardrails).

---

## 1. Executive Summary

Following the completion of the read-only forensic audit, which proved that Condition C1 eliminates 100% of treatment duration boundary leakage into dosage and frequency fields while apparent regressions were purely evaluation-contract artifacts, the validated medication field-boundary rules have been integrated into production narrative extraction.

### Core Implementation Accomplishments:
1. **Dose vs Treatment Duration Separation:**
   - Explicitly forbids treatment durations (e.g. `"6 weeks"`, `"5 days"`, `"3 months"`, `"for 10 days"`) from entering `med.dose` or `med.frequency`.
   - Protects physical dosage amounts (e.g. `"500 mg"`, `"1 g"`, `"5 mL"`, `"10 units"`) as valid `med.dose` claims.
2. **Frequency vs Route vs Dosage Form Disambiguation:**
   - Dosing frequency schedules (e.g. `"once daily"`, `"twice daily"`, `"every 8 hours"`, `"every 3 weeks"`, `"PRN"`, `"as needed"`) are strictly bounded to `med.frequency`.
   - Anatomical administration paths (e.g. `"oral"`, `"by mouth"`, `"PO"`, `"intravenous"`, `"IV"`) remain in `med.route`.
   - Dosage forms (`"tablet"`, `"tab"`, `"capsule"`, `"syrup"`, `"injection"`) are explicitly excluded from `med.route`, `med.frequency`, and `med.dose`.
3. **Verbatim Route Rule Enforced:**
   - Unlike the experimental C1 prompt, the production prompt explicitly mandates verbatim copying of route tokens (e.g. `"by mouth"` remains `med.route = "by mouth"` and is NOT canonicalized to `"oral"`).
4. **Source-Faithful Compound Token Preservation:**
   - Rejects artificial prefix-stripping for abbreviated compound drugs. Tokens such as `"C.Autrin"` and `"T.Shelcal"` remain preserved as written, matching the authoritative CMC Vellore holdout ground truth.
5. **PD-022 Laboratory Invariance:**
   - Zero changes made to qualitative/quantitative laboratory logic, prompts, normalizers, or schemas. All 14 PD-022 qualitative lab tests passed with 100% fidelity.

---

## 2. Exact Production Files Modified

| File | Change Description |
|---|---|
| [`src/clindoc/extract/llm_extractor.py`](file:///d:/daa/src/clindoc/extract/llm_extractor.py) | Integrated proven medication field-boundary rules, verbatim route rule, source-faithful prefix preservation, and updated few-shot exemplars in `_SYSTEM_PROMPT`. Updated `MockLLMProvider` route extraction to preserve verbatim casing. |

*No other production files, schemas, normalizers, FHIR mappers, layout gates, or specifications were modified.*

---

## 3. Exact Prompt & Rule Changes

The `_SYSTEM_PROMPT` in [`src/clindoc/extract/llm_extractor.py`](file:///d:/daa/src/clindoc/extract/llm_extractor.py) was updated with the following explicit rules:

```text
CRITICAL EXTRACTION RULES:
1. DOSE VS UNIT SEPARATION & DURATION BOUNDARY:
   - med.dose contains ONLY the physical numeric quantity per administration (e.g. "0.5", "6.25", "10", "1", "500").
   - unit_raw contains the unit of measure (e.g. "ml", "mg", "g", "mcg", "units").
   - NEVER put the unit inside med.dose.
   - NEVER use evidence_text, field names, or surrounding prose as the dose value.
   - DOSE VS TREATMENT DURATION: Course durations or treatment periods (e.g. "6 weeks", "5 days", "3 months", "for 10 days", "for 30 days") represent the total treatment duration, NOT the dose and NOT the frequency. NEVER extract treatment durations or time periods into med.dose or med.frequency.
   - Physical medication doses (e.g. "500 mg", "1 g", "5 mL", "10 units") must remain med.dose.

2. FREQUENCY VS ROUTE & DOSAGE FORM BOUNDARY:
   - med.frequency represents WHEN or HOW OFTEN the drug is taken (e.g. "once daily", "twice daily", "three times daily", "every 8 hours", "every 3 weeks", "PRN", "as needed", "as and when needed"). NEVER classify frequency or timing as med.route.
   - med.route represents WHERE or HOW the drug enters the body (e.g. "oral", "by mouth", "PO", "intravenous", "IV", "subcutaneous", "SC").
   - VERBATIM ROUTE RULE: Extract the route wording EXACTLY as written in the source text (e.g. if the text says "by mouth", extract value "by mouth", do NOT replace with "oral"; if the text says "PO", extract value "PO"). Canonical route normalization occurs downstream.
   - DOSAGE FORM SEPARATION: Dosage forms such as "tablet", "tab", "capsule", "cap", "syrup", "injection" are DOSAGE FORMS, NOT routes, NOT frequencies, and NOT doses. NEVER extract dosage forms into med.route, med.frequency, or med.dose.

3. MEDICATION NAMES & DOSAGE FORMS:
   - Strip standalone dosage-form prefixes such as "TAB", "SYP", "CAP", "INJ", "Tab" from med.name when separated by whitespace (e.g. "TAB ALDACTONE" -> value: "Aldactone", "SYP FUROPED" -> value: "Furoped").
   - Preserve source-faithful tokens for abbreviated compound medications (e.g. "C.Autrin" -> value: "C.Autrin", "T.Shelcal" -> value: "T.Shelcal"). Do not strip prefixes when part of the source token.
   - Do NOT include dosage forms, route, or frequency in med.name.

4. COMPOUND PRESCRIPTIONS & INLINE ORDERS:
   - A single prescription line or sentence may contain multiple medication entities.
   - When genuinely separate medications are listed together in a slash-delimited or co-prescribed order (e.g. "C.Autrin / T.Shelcal once daily for 6 weeks"):
     a) Extract EACH distinct medication as its own med.name claim (e.g. "C.Autrin", "T.Shelcal").
     b) Propagate the shared dosing frequency to EACH co-prescribed medication (e.g. "once daily" for each).
     c) Do NOT extract the duration ("6 weeks") as a dose or frequency.
   - In inline medication sentences (e.g. "Tab Paracetamol 500mg as and when needed", "Tab Metacin 1g as and when needed"):
     ALWAYS extract the medication active name as med.name (e.g. "Paracetamol", "Metacin"); do NOT omit the medication name merely because dose, frequency, or indication follow it.

5. DO NOT SPLIT COMBINATION DRUGS OR CLINICAL SLASH TERMS:
   - Genuine single combination medications containing slashes or hyphens (e.g. "Amoxicillin/clavulanate", "Trimethoprim/sulfamethoxazole", "Sulfamethoxazole/trimethoprim") are single drug entities: extract the full combination name as a single med.name; do NOT split them into separate drugs.
   - Clinical slash terms, ratios, or lab tests (e.g. "PT/INR", "HIV/HBsAg", "BP: 120/80") are NOT medication co-prescriptions. Do NOT treat them as medications.
```

---

## 4. Tests Added & Verification Results

### Focused Test Suite: [`tests/test_medication_boundaries.py`](file:///d:/daa/tests/test_medication_boundaries.py)
A dedicated 12-test suite was implemented covering all required boundary criteria:

| Test Name | Validated Invariant | Result |
|---|---|:---:|
| `test_prompt_contract_integrity` | Verifies all prompt rules, exemplars, and PD-022 lab invariants | **PASSED** |
| `test_duration_6_weeks_is_not_med_dose` | `"6 weeks"` is NOT extracted as `med.dose` | **PASSED** |
| `test_duration_5_days_is_not_med_dose` | `"for 5 days"` is NOT extracted as `med.dose` | **PASSED** |
| `test_duration_for_10_days_is_not_med_frequency` | `"for 10 days"` is NOT extracted as `med.frequency` | **PASSED** |
| `test_duration_for_3_months_is_not_med_frequency` | `"for 3 months"` is NOT extracted as `med.frequency` | **PASSED** |
| `test_500_mg_remains_med_dose` | `"500 mg"` remains `med.dose = "500"`, `unit = "mg"` | **PASSED** |
| `test_once_daily_remains_med_frequency` | `"once daily"` remains `med.frequency` | **PASSED** |
| `test_by_mouth_remains_verbatim_med_route` | `"by mouth"` remains verbatim `med.route = "by mouth"` | **PASSED** |
| `test_tablet_does_not_become_med_frequency_or_route` | Dosage form `"tablet"` is excluded from route and frequency | **PASSED** |
| `test_source_faithful_c_autrin_and_t_shelcal` | `"C.Autrin"` & `"T.Shelcal"` remain source-faithful | **PASSED** |
| `test_combination_drugs_with_slash_remain_single_entity` | `"Amoxicillin/clavulanate"` & `"Sulfamethoxazole/trimethoprim"` not split | **PASSED** |
| `test_pd022_qualitative_and_quantitative_invariance` | `HBsAg Negative`, `HIV Negative`, `VDRL Non-Reactive`, `Hb 12.6 GM%` | **PASSED** |

**Focused Suite Summary:** **12 passed, 0 failed in 7.63s**.

---

## 5. Extraction Regression Results

A comprehensive 6-suite regression execution was performed across the extraction and normalization subsystems:

```
tests\test_medication_boundaries.py ............                         [ 15%]
tests\test_compound_medications.py .......                               [ 24%]
tests\test_pd022_qualitative_labs.py ..............                      [ 42%]
tests\test_terminology_normalization.py ........................         [ 73%]
tests\test_whitespace_grounding.py .........                             [ 84%]
tests\test_failure_modes_f05_f07.py ............                         [100%]

============================= 78 passed in 48.48s =============================
```

In addition, FHIR mapping and broader extraction subsystem suites were verified:
```
tests\test_canonical_fhir_mapping.py ...........                         [ 10%]
tests\test_extraction_subsystem.py ..................................... [ 45%]
.........................................................                [100%]

============================= 105 passed in 8.33s =============================
```

**Total Tests Verified:** **183 passed, 0 failed.**

---

## 6. Confirmation of PD-022 Behavior Preservation

PD-022 laboratory extraction and normalization invariants were rigorously verified:
1. **Prompt Invariants Preserved:**
   - `"quantitative numeric laboratory test result value"` preserved.
   - `"grounded qualitative laboratory determination"` preserved.
   - `"HBsAg: Negative"`, `"HIV: Negative"`, `"VDRL: Non-Reactive"` exemplars preserved.
   - Specimen commentary negative rule preserved.
2. **Deterministic & Normalization Invariants Preserved:**
   - `HBsAg: Negative` $\rightarrow$ `lab.value = "Negative"`, `normalized_code = "NEGATIVE"` (PASSED)
   - `HIV ELISA: Negative` $\rightarrow$ `lab.value = "Negative"`, `normalized_code = "NEGATIVE"` (PASSED)
   - `VDRL: Non-Reactive` $\rightarrow$ `lab.value = "Non-Reactive"`, `normalized_code = "NON_REACTIVE"` (PASSED)
   - `HAEMOGLOBIN: 12.6 GM%` $\rightarrow$ `lab.value = "12.6"`, `unit = "GM%"`, `value_numeric = 12.6` (PASSED)
3. **Qualitative Regression Status:** **0% regression (All 14 PD-022 tests passed).**

---

## 7. Known Limitations & Scope Boundaries

1. **Duration Field Entity Type:**
   - Treatment duration is deliberately suppressed from entering `med.dose` or `med.frequency` to prevent clinical dose misinterpretation. Duration is not currently part of the canonical 10-field Tier 1 vocabulary (`DEC-017`/`DEC-020`). If full duration representation is required in FHIR `MedicationRequest.dispenseRequest.expectedSupplyDuration`, a dedicated Tier 2 field or extension may be introduced in a future decision.
2. **Unchanged Layout & Downstream Architecture:**
   - No changes were made to layout serialization, OCR token extraction, OCR bounding-box gating, or downstream verification cascade logic.

---

## 8. Final Verification Checklist

- **Production files modified:** 1 ([`src/clindoc/extract/llm_extractor.py`](file:///d:/daa/src/clindoc/extract/llm_extractor.py))
- **Test files created:** 1 ([`tests/test_medication_boundaries.py`](file:///d:/daa/tests/test_medication_boundaries.py))
- **Report files created:** 1 ([`reports/MEDICATION_BOUNDARY_IMPLEMENTATION_REPORT.md`](file:///d:/daa/reports/MEDICATION_BOUNDARY_IMPLEMENTATION_REPORT.md))
- **Unrelated production files modified:** **0 (Strictly zero)**
- **Total regression tests passed:** **183 passed, 0 failed**
- **Git status:** Completely uncommitted and unstaged.
